[
  {
    "ts": null,
    "headline": "Truist Maintains Hold on Insperity (NSP), Lowers Price Target to $35",
    "summary": "Insperity, Inc. (NYSE:NSP) is included among the 15 Best 52-Week Low Dividend Stocks to Invest in. On November 4, Truist analyst Tobey​ Sommer lowered‌ the price targ‍et on Insperity, Inc. (NYSE:NSP) to‌ $35 from‌ $50 while m‍ain‍tain‌ing a Hold ratin‍g on the s‍hares, according to a report by The Fly. The a‌nalyst noted that the […]",
    "url": "https://finnhub.io/api/news?id=112fabbaa4d717f8a21381e49c87e01de9a01554c0657452cffe4bc118214c5a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763404986,
      "headline": "Truist Maintains Hold on Insperity (NSP), Lowers Price Target to $35",
      "id": 137506611,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Insperity, Inc. (NYSE:NSP) is included among the 15 Best 52-Week Low Dividend Stocks to Invest in. On November 4, Truist analyst Tobey​ Sommer lowered‌ the price targ‍et on Insperity, Inc. (NYSE:NSP) to‌ $35 from‌ $50 while m‍ain‍tain‌ing a Hold ratin‍g on the s‍hares, according to a report by The Fly. The a‌nalyst noted that the […]",
      "url": "https://finnhub.io/api/news?id=112fabbaa4d717f8a21381e49c87e01de9a01554c0657452cffe4bc118214c5a"
    }
  },
  {
    "ts": null,
    "headline": "Truist Financial Raises the PT on Pediatrix Medical (MD), Keeps a Buy",
    "summary": "​Pediatrix Medical Group, Inc. (NYSE:MD) is one of the Hottest Small Cap Stocks to Buy Now. On November 10, David S Macdonald from Truist Financial raised the firm’s price target on Pediatrix Medical Group, Inc. (NYSE:MD) from $17 to $24, while reiterating a Buy rating. ​The enhanced positive outlook follows a 33.59% increase in share […]",
    "url": "https://finnhub.io/api/news?id=a2a6434962a61023b5bc6089a473d722006b04a3b2ed8de56f401c887362a905",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763399749,
      "headline": "Truist Financial Raises the PT on Pediatrix Medical (MD), Keeps a Buy",
      "id": 137506612,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "​Pediatrix Medical Group, Inc. (NYSE:MD) is one of the Hottest Small Cap Stocks to Buy Now. On November 10, David S Macdonald from Truist Financial raised the firm’s price target on Pediatrix Medical Group, Inc. (NYSE:MD) from $17 to $24, while reiterating a Buy rating. ​The enhanced positive outlook follows a 33.59% increase in share […]",
      "url": "https://finnhub.io/api/news?id=a2a6434962a61023b5bc6089a473d722006b04a3b2ed8de56f401c887362a905"
    }
  },
  {
    "ts": null,
    "headline": "Block upgraded, Dell downgraded: Wall Street's top analyst calls",
    "summary": "Block upgraded, Dell downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=f9d6485cf567d4d9c539dc3c9ccc754daac01ad5a483e6434f07a4c3ec2ebdaa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763390045,
      "headline": "Block upgraded, Dell downgraded: Wall Street's top analyst calls",
      "id": 137506613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Block upgraded, Dell downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=f9d6485cf567d4d9c539dc3c9ccc754daac01ad5a483e6434f07a4c3ec2ebdaa"
    }
  },
  {
    "ts": null,
    "headline": "Truist introduces team covering middle-market private equity sponsors, family offices",
    "summary": "Truist Financial Corporation (NYSE: TFC) announced the appointment of Chris Jackson as head of its newly established Institutional Capital Group, which will serve middle-market private equity sponsors and select family offices. The new team will increase Truist's coverage in the growing small- and mid-cap private equity market.",
    "url": "https://finnhub.io/api/news?id=cf91890042324462551501bab29ec1c34ee5c0e078ba0ef76132c8827125f9c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763388780,
      "headline": "Truist introduces team covering middle-market private equity sponsors, family offices",
      "id": 137506614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Truist Financial Corporation (NYSE: TFC) announced the appointment of Chris Jackson as head of its newly established Institutional Capital Group, which will serve middle-market private equity sponsors and select family offices. The new team will increase Truist's coverage in the growing small- and mid-cap private equity market.",
      "url": "https://finnhub.io/api/news?id=cf91890042324462551501bab29ec1c34ee5c0e078ba0ef76132c8827125f9c9"
    }
  },
  {
    "ts": null,
    "headline": "How Recent Developments Are Rewriting the Story for Pinnacle Financial Partners",
    "summary": "Pinnacle Financial Partners has recently seen its consensus analyst price target decrease modestly from $107.77 to $107.08. This reflects a slightly lower fair value estimate as perspectives in the market shift. The update comes as analysts weigh the opportunities and challenges arising from the ongoing integration with Synovus. Some analysts highlight improved revenue prospects, while others remain cautious due to uncertainties related to the merger. Stay tuned to discover how you can keep...",
    "url": "https://finnhub.io/api/news?id=bf3fe213377cc2993f2213220c2185da64ec625419ff4bd8b846061450319ec9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763363463,
      "headline": "How Recent Developments Are Rewriting the Story for Pinnacle Financial Partners",
      "id": 137504299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Pinnacle Financial Partners has recently seen its consensus analyst price target decrease modestly from $107.77 to $107.08. This reflects a slightly lower fair value estimate as perspectives in the market shift. The update comes as analysts weigh the opportunities and challenges arising from the ongoing integration with Synovus. Some analysts highlight improved revenue prospects, while others remain cautious due to uncertainties related to the merger. Stay tuned to discover how you can keep...",
      "url": "https://finnhub.io/api/news?id=bf3fe213377cc2993f2213220c2185da64ec625419ff4bd8b846061450319ec9"
    }
  },
  {
    "ts": null,
    "headline": "Q3 Rundown: Truist Financial (NYSE:TFC) Vs Other Diversified Banks Stocks",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how diversified banks stocks fared in Q3, starting with Truist Financial (NYSE:TFC).",
    "url": "https://finnhub.io/api/news?id=4a2a69a770a667829113e28e875d4a850e21df6d4023b8c84eb4f7332c152094",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763350334,
      "headline": "Q3 Rundown: Truist Financial (NYSE:TFC) Vs Other Diversified Banks Stocks",
      "id": 137504300,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how diversified banks stocks fared in Q3, starting with Truist Financial (NYSE:TFC).",
      "url": "https://finnhub.io/api/news?id=4a2a69a770a667829113e28e875d4a850e21df6d4023b8c84eb4f7332c152094"
    }
  },
  {
    "ts": null,
    "headline": "How the Narrative Around Quest Diagnostics Is Evolving After Recent Results and Analyst Updates",
    "summary": "Quest Diagnostics' fair value estimate remains steady at $197.25 per share, with only a slight uptick in the discount rate. This reflects minimal change in the firm's valuation assessment. While the company continues to project steady revenue growth, recent analyst sentiment highlights both enthusiasm and caution following strong quarterly results and an impressive guidance update. Stay tuned to discover how evolving analyst views and company performance can help you navigate future updates...",
    "url": "https://finnhub.io/api/news?id=b6b8d8648362df74bfb115dd0cdcfd0b54ce1339cc653e2725872542d84f162e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763338467,
      "headline": "How the Narrative Around Quest Diagnostics Is Evolving After Recent Results and Analyst Updates",
      "id": 137502144,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Quest Diagnostics' fair value estimate remains steady at $197.25 per share, with only a slight uptick in the discount rate. This reflects minimal change in the firm's valuation assessment. While the company continues to project steady revenue growth, recent analyst sentiment highlights both enthusiasm and caution following strong quarterly results and an impressive guidance update. Stay tuned to discover how evolving analyst views and company performance can help you navigate future updates...",
      "url": "https://finnhub.io/api/news?id=b6b8d8648362df74bfb115dd0cdcfd0b54ce1339cc653e2725872542d84f162e"
    }
  }
]